Hernández-Valencia M - Search Results

1

Treatment of menopausal symptoms with three low-dose continuous sequential 17β-estradiol/progesterone parenteral monthly formulations using novel non-polymeric microsphere technology.

Cortés-Bonilla M, Bernardo-Escudero R, Alonso-Campero R, Francisco-Doce MT, Hernández-Valencia M, Celis-González C, Márquez-Oñate R, Chedraui P, Uribe JA. Cortés-Bonilla M, et al. Gynecol Endocrinol. 2015 Jul;31(7):552-9. doi: 10.3109/09513590.2015.1019853. Epub 2015 Jun 10. Gynecol Endocrinol. 2015. PMID: 26062108 Free PMC article. Clinical Trial.

2

[Consensus conference of the Mexican Association for the Study of Climateric on veralipride prescription for patients with vasomotor symptoms].

Basavilvazo-Rodríguez A, Bravo-Rodríguez LM, Carranza-Lira S, Celis-González C, Hernández Marín I, Hernández-Valencia M, López Navarro ME, Alvarado Maldonado Jde D, Armando Montaño J, Moreno Avellán AJ, Vázquez G. Basavilvazo-Rodríguez A, et al. Ginecol Obstet Mex. 2012 Jul;80(7):467-72. Ginecol Obstet Mex. 2012. PMID: 22916640 Spanish.

3

Conjugated estrogens and tibolone modify the gonadotrophin glycosylation pattern in postmenopausal women.

Hernandez-Valencia M, Zarate A, Sandoval A, Ruiz M, Timossi C, Amato D, Basurto L. Hernandez-Valencia M, et al. Gynecol Obstet Invest. 2007;63(1):22-7. doi: 10.1159/000094673. Epub 2006 Jul 20. Gynecol Obstet Invest. 2007. PMID: 16864983 Clinical Trial.

4

[Estrogen therapy in menopause. Clinical study in evolution (KEEPS) to explain the risk-benefit dispute to administration].

Zárate A, Hernández-Valencia M. Zárate A, et al. Ginecol Obstet Mex. 2010 Mar;78(3):191-4. Ginecol Obstet Mex. 2010. PMID: 20939224 Spanish.

5

[Therapy with dehidroepiandrosterone improves symptoms in perimenopausal women].

Hernández Valencia M, Angeles L, Saucedo R, Basurto L, Zárate A. Hernández Valencia M, et al. Ginecol Obstet Mex. 2005 May;73(5):245-9. Ginecol Obstet Mex. 2005. PMID: 21966763 Clinical Trial. Spanish.

6

[Hypothyroidism associated to menopause symptoms worsening change with thyroid substitution therapy].

Hernández Valencia M, Córdova Pérez N, Zárate A, Basurto L, Manuel Apolinar L, Ruiz M, Vargas C, Vargas A. Hernández Valencia M, et al. Ginecol Obstet Mex. 2008 Oct;76(10):571-5. Ginecol Obstet Mex. 2008. PMID: 19062505 Spanish.

7

[Current position about the use of estrogen therapy in women during the climacteric period].

Zárate A, Hernández-Valencia M, Saucedo R, Basurto L, Manuel-Apolinar L. Zárate A, et al. Rev Med Inst Mex Seguro Soc. 2014 Jan-Feb;52(1):66-9. Rev Med Inst Mex Seguro Soc. 2014. PMID: 24625486 Spanish.

8

[Frequency of symptoms of the climacteric syndrome].

Hernández-Valencia M, Córdova-Pérez N, Basurto L, Saucedo R, Vargas C, Vargas A, Ruiz M, Manuel L, Zárate A. Hernández-Valencia M, et al. Ginecol Obstet Mex. 2010 Apr;78(4):232-7. Ginecol Obstet Mex. 2010. PMID: 20939230 Spanish.

9

[Maternal and perinatal surgical complications in low platelet count for HELLP syndrome in severe preeclampsia-eclampsia in intensive care].

Basavilvazo Rodríguez A, Pacheco Pérez C, Lemus Rocha R, Martínez Pérez JM, Martínez Martínez A, Hernández-Valencia M. Basavilvazo Rodríguez A, et al. Ginecol Obstet Mex. 2003 Aug;71:379-86. Ginecol Obstet Mex. 2003. PMID: 14619691 Spanish.

10

[Breast cancer and subsequent pregnancy. Infertility, death risk and survival].

Ramírez-Torres N, Robles-Robles AG, Villafaña-Vázquez VH, Hernández-Valencia M. Ramírez-Torres N, et al. Ginecol Obstet Mex. 2010 Feb;78(2):85-93. Ginecol Obstet Mex. 2010. PMID: 20939209 Spanish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

91 results

Search Page